The FDA on Friday granted marketing authorization to the first at-home test for diagnosing chlamydia, gonorrhea, and trichomoniasis in females. The so-called Visby Medical Women's Sexual Health Test ...
These tests offer increased sensitivity because they are able to produce a positive signal from a single copy of target DNA or RNA. In addition to being able to screen endocervical and urethral swabs, ...
The FDA has granted marketing authorization to Visby Medical for the first at-home diagnostic test for chlamydia, gonorrhea and trichomoniasis that does not require a prescription. The test includes a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback